Fundraising Fox
Solaris Pharma
Bridgewater, US · Founded 2014 · 1 known investors
Find your way into Solaris Pharma
Sign up to see every warm intro you have to Solaris Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solaris Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.
Founders & leadership
SL
Srinivasan Lakshmi RaghavanExecutive
SJ
Shalin JaniPresident & CEO
KA
Kamlesh AminVice President, AR&DKamlesh Amin is Vice President of Analytical Research & Development at Solaris Pharma, where he leads work on generic and specialty pharmaceutical formulations. He has extensive experience in analytical method development and validation for pharmaceutical products, with expertise in spectroscopic and chromatographic techniques and knowledge of cGMP, GLP, and ICH regulatory guidelines.
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.4M disclosed across 2 of 3 rounds · 2016–2019
▶$10MraisedJan 2020 · 6 investors · PharmaceuticalsRule 506(b)
▶$10MraisedJan 2020 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernhard HamplDirector
- Srinivas Lakshmi RaghavanExecutive Officer, Director
- Manish PottiDirector
- Satish PejaverExecutive Officer, Director
- Helmut JeggleDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Dec 2019
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2018 · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedAug 2018 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Srinivasan Lakshmi RaghavanDirector
- Incorporated
- Corporation, New Jersey, 2014
- Federal exemptions
- 06b
▶$13.4MraisedNov 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$13.4MraisedNov 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Srinivasan Lakshmi RaghavanExecutive Officer, Director
- Offering amount
- $13.4M
- Amount sold
- $13.4M
- Minimum investment
- $219K
- Incorporated
- Corporation, New Jersey, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Solaris Pharma.
Frequently asked questions
- What does Solaris Pharma do?
- Solaris Pharma develops and supplies generic and specialty pharmaceutical products including topical, sterile, and tablet formulations. The company serves patients seeking high-quality, affordable therapeutic alternatives with an emphasis on regulatory compliance and manufacturing reliability.
- Who are Solaris Pharma's investors?
- Solaris Pharma's investors include Salvia.
- How much funding has Solaris Pharma raised?
- Solaris Pharma has disclosed $23.4M raised across 2 of its 3 known rounds.
- Where is Solaris Pharma headquartered?
- Solaris Pharma is headquartered in Bridgewater, US.